TY - JOUR
T1 - Stem Cells and Congenital Heart Disease
T2 - The Future Potential Clinical Therapy Beyond Current Treatment
AU - Julian, Katherine
AU - Garg, Nikita
AU - Hibino, Narutoshi
AU - Jain, Rohit
N1 - Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Congenital heart disease (CHD) is the most common congenital anomaly in newborns. Current treatment for cyanotic CHD largely relies on the surgical intervention; however, signifi-cant morbidity and mortality for patients with CHD remain. Recent research to explore new ave-nues of treating CHD includes the utility of stem cells within the field. Stem cells have since been used to both model and potentially treat CHD. Most clinical applications to date have focused on hypoplastic left heart syndrome. Here, we examine the current role of stem cells in CHD and discuss future applications within the field.
AB - Congenital heart disease (CHD) is the most common congenital anomaly in newborns. Current treatment for cyanotic CHD largely relies on the surgical intervention; however, signifi-cant morbidity and mortality for patients with CHD remain. Recent research to explore new ave-nues of treating CHD includes the utility of stem cells within the field. Stem cells have since been used to both model and potentially treat CHD. Most clinical applications to date have focused on hypoplastic left heart syndrome. Here, we examine the current role of stem cells in CHD and discuss future applications within the field.
UR - http://www.scopus.com/inward/record.url?scp=85148938093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148938093&partnerID=8YFLogxK
U2 - 10.2174/1573403X18666220531093326
DO - 10.2174/1573403X18666220531093326
M3 - Short survey
C2 - 35642109
AN - SCOPUS:85148938093
SN - 1573-403X
VL - 19
JO - Current Cardiology Reviews
JF - Current Cardiology Reviews
IS - 2
M1 - e310522205424
ER -